| 11161819 |
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists |
Gregory L. Adams, Jason M. Cox, John S. Debenham, Scott D. Edmondson, Eric J. Gilbert +15 more |
2021-11-02 |
$152,718,000 |
| 10875851 |
Factor XIIa inhibitors |
Ashwin U. Rao, Brian McKittrick, Matthew Lombardo, Jacqueline D. Hicks, Amy Bittner McCracken +12 more |
2020-12-29 |
$201,093,000 |
| 10864211 |
Hydroxy isoxazole compounds useful as GPR120 agonists |
John S. Debenham, Jason M. Cox, Zhongxiang Sun, Zhe Feng, Chunrui Sun +9 more |
2020-12-15 |
$366,193,000 |
| 9708270 |
Substituted spiropiperidinyl compounds useful as GPR120 agonists |
Mariappan V. Chelliah, Hong Dong Chu, Jason M. Cox, John S. Debenham, Keith Eagen +7 more |
2017-07-18 |
$61,300,000 |
| 9487506 |
Mineralocorticoid receptor antagonists |
Kun Liu, Anthony Ogawa, Hong Shen, Christine Yang, Yuguang Wang +2 more |
2016-11-08 |
$82,214,000 |
| 9403807 |
Mineralocorticoid receptor antagonists |
Alejandro Crespo, Rudrajit Mal, Anthony Ogawa, Hong Shen, Peter J. Sinclair +11 more |
2016-08-02 |
$113,135,000 |
| 8933113 |
Mineralocorticoid receptor antagonists |
Alejandro Crespo, Rudrajit Mal, Anthony Ogawa, Hong Shen, Peter J. Sinclair +11 more |
2015-01-13 |
$113,299,000 |
| 8563746 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents |
Qun Dang, De Michael Chung, Tony S. Gibson, Hongjian Jiang, Daniel K. Cashion +6 more |
2013-10-22 |
$71,032,000 |
| 8410284 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents |
Qun Dang, Tony S. Gibson, Hongjian Jiang, De Michael Chung, Jianming Bao +10 more |
2013-04-02 |
$79,692,000 |
| 8394969 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents |
Brett C. Bookser, Qun Dang, Tony S. Gibson, Hongjian Jiang, De Michael Chung +10 more |
2013-03-12 |
$65,416,000 |
| 8329914 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents |
Jianming Bao, Huagang Lu, Gergely M. Makara, F. Anthony Romero, Iyassu Sebhat +6 more |
2012-12-11 |
$46,772,000 |
